Table 5. Oxidative stress marker levels and fetal outcomes in the subgroups of pregnant women with sleep deprivation using PSQI score (group I score <18 and group II score >18).
| Variables | Sleep deprived pregnant women (n=30) | ||
|---|---|---|---|
| Group I (n=14) | Group II (n=16) | p-value | |
| Folate (ng/mL) | 4.4±3.8 | 3.8±4.3 | 0.476 |
| Vitamin B12 (pg/mL) | 222.6±57.0 | 217.0±74.0 | 0.712 |
| Homocysteine (µmol/L) | 13.4±4.3 | 14.3±9.1 | 0.081 |
| hsCRP (ng/mL) | 6108.3±3877.0 | 5006.0±3599.0 | 0.331 |
| Malendialdehyde (µmol/L) | 5.2±1.8 | 6.8±1.4* | 0.001 |
| Protein carbonyls (nmol/mg protein) |
6.5±1.1 | 7.8±3.3* | 0.034 |
| PBSA (µg/mg protein) | 3.7±0.71 | 3.8±0.8 | 0.131 |
| Birth weight (kg) | 2.9±0.4 | 2.6±0.4* | 0.021 |
| APGAR score | 8.5±0.5 | 8.1±0.6* | 0.011 |
*p<0.050 when compared with pregnant women with low sleep deprivation using Student’s t-test and Mann-Whitney U test for parametric and nonparametric data, respectively. hsCRP: high-sensitivity C-reactive protein; PBSA: protein-bound sialic acid.